Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections

Zermatten, 2020, Hemostatic alterations in patients with cirrhosis: from primary hemostasis to fibrinolysis, Hepatology, 71, 2135, 10.1002/hep.31201 Lisman, 2020, Bleeding and thrombosis in patients with liver diseases, Semin Thromb Hemost, 46, 653, 10.1055/s-0040-1715453 Zanetto, 2021, Reduced clot stability by thromboelastography as a potential indicator of procedure-related bleeding in decompensated cirrhosis, Hepatol Commun, 5, 272, 10.1002/hep4.1641 Zanetto, 2017, Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma, Dig Liver Dis, 49, 440, 10.1016/j.dld.2016.12.019 Northup, 2021, Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases, Hepatology, 73, 366, 10.1002/hep.31646 Villa, 2022, EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis, J Hepatol, 10.1016/j.jhep.2021.09.003 Roberts, 2021, Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: guidance from the SSC of the ISTH, J Thromb Haemost Zanetto, 2020, Acute kidney injury in decompensated cirrhosis is associated with both hypo-coagulable and hyper-coagulable features, Hepatology, 72, 1327, 10.1002/hep.31443 Intagliata, 2019, Acute kidney injury is associated with low factor XIII in decompensated cirrhosis, Dig Liver Dis, 51, 1409, 10.1016/j.dld.2019.03.011 Hung, 2018, Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis, Liver Int, 38, 1437, 10.1111/liv.13712 Fernandez, 2021, Management of bacterial and fungal infections in cirrhosis: the MDRO challenge, J Hepatol, 75, S101, 10.1016/j.jhep.2020.11.010 Caly, 1993, A prospective study of bacterial infections in patients with cirrhosis, J Hepatol, 18, 353, 10.1016/S0168-8278(05)80280-6 Bernard, 1995, Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study, Gastroenterology, 108, 1828, 10.1016/0016-5085(95)90146-9 Goulis, 1998, Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage, Hepatology, 27, 1207, 10.1002/hep.510270504 Zanetto, 2021, Recent advances in the management of acute variceal hemorrhage, J Clin Med, 10 Kundumadam, 2020, Bleeding after elective interventional endoscopic procedures in a large cohort of patients with cirrhosis, Clin Transl Gastroenterol, 11, 10.14309/ctg.0000000000000288 Montalto, 2002, Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study, J Hepatol, 37, 463, 10.1016/S0168-8278(02)00208-8 2018, EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis, J Hepatol, 69, 406, 10.1016/j.jhep.2018.03.024 de Franchis, 2022, Baveno VII - renewing consensus in portal hypertension, J Hepatol, 76, 959, 10.1016/j.jhep.2021.12.022 Trebicka, 2021, PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis, J Hepatol, 74, 1097, 10.1016/j.jhep.2020.11.019 Schulman, 2005, Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients, J Thromb Haemost, 3, 692, 10.1111/j.1538-7836.2005.01204.x Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 1426, 10.1053/j.gastro.2013.02.042 Campello, 2021, Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure, Liver Int, 10.1111/liv.15001 Lisman, 2021, Global hemostatic status in patients with acute-on-chronic liver failure and septics without underlying liver disease, J Thromb Haemost, 19, 85, 10.1111/jth.15112 von Meijenfeldt, 2021, Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease, J Thromb Haemost, 19, 664, 10.1111/jth.15185 Zanetto, 2021, Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis, Cancers (Basel), 13, 10.3390/cancers13051150 Zanetto, 2021, More pronounced hypercoagulable state and hypofibrinolysis in patients with cirrhosis with vs. without HCC, Hepatol Commun, 10.1002/hep4.1781 Zanetto, 2022, Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications, Liver Int, 10.1111/liv.15183 Singer, 2016, The third international consensus definitions for sepsis and septic shock (Sepsis-3), JAMA, 315, 801, 10.1001/jama.2016.0287 Campello, 2015, Hypercoagulability detected by whole blood thromboelastometry (ROTEM(R)) and impedance aggregometry (MULTIPLATE(R)) in obese patients, Thromb Res, 135, 548, 10.1016/j.thromres.2015.01.003 Russo, 2018, Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals, Liver Int, 38, 2210, 10.1111/liv.13873 Angeli, 2019, News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document, J Hepatol, 71, 811, 10.1016/j.jhep.2019.07.002 Campello, 2021, Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis, Dig Liver Dis, 53, 879, 10.1016/j.dld.2020.12.118 Jackson, 2007, The growing complexity of platelet aggregation, Blood, 109, 5087, 10.1182/blood-2006-12-027698 Caldwell, 2017, The cirrhotic platelet: shedding light on an enigma, Hepatology, 65, 407, 10.1002/hep.28931 Semmler, 2021, Noninvasive risk stratification after HCV eradication in patients with advanced chronic liver disease, Hepatology, 73, 1275, 10.1002/hep.31462 Aird, 2003, The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome, Blood, 101, 3765, 10.1182/blood-2002-06-1887 Potze, 2017, Reply to: "Procoagulant imbalance in patients with non-alcoholic fatty liver disease", J Hepatol, 66, 250, 10.1016/j.jhep.2016.10.011 de Laat-Kremers, 2020, Towards standardization of thrombin generation assays: inventory of thrombin generation methods based on results of an International Society of Thrombosis and Haemostasis Scientific Standardization Committee survey, J Thromb Haemost, 18, 1893, 10.1111/jth.14863 Lisman, 2010, Hemostasis and thrombosis in patients with liver disease: the ups and downs, J Hepatol, 53, 362, 10.1016/j.jhep.2010.01.042 Ow, 2021, Prevalence of bleeding and thrombosis in critically ill patients with chronic liver disease, Thromb Haemost Mucino-Bermejo, 2015, Thrombosis and hemorrhage in the critically ill cirrhotic patients: five years retrospective prevalence study, Ann Hepatol, 14, 93, 10.1016/S1665-2681(19)30805-1 Stine, 2018, Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis, Clin Transl Gastroenterol, 9, 140, 10.1038/s41424-018-0002-y Vervloet, 1998, Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock, Semin Thromb Hemost, 24, 33, 10.1055/s-2007-995821